Pharmaceutical Companies: The Perfect Scapegoat for Everything

American Journal of Bioethics 13 (5):30-32 (2013)
  Copy   BIBTEX

Abstract

No abstract

Categories

Keywords

Reprint years

DOI

10.1080/15265161.2013.776143

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,122

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines.Joo-Young Lee & Paul Hunt - 2012 - Journal of Law, Medicine and Ethics 40 (2):220-233.
How Pharmaceutical Industry Employees Manage Competing Commitments in the Face of Public Criticism.Wendy Lipworth, Kathleen Montgomery & Miles Little - 2013 - Journal of Bioethical Inquiry 10 (3):355-367.
Pharmaceutical companies and access to medicines – social integration and ethical CSR resolution of a global public choice problem.Onyeka K. Osuji & Okechukwu Timothy Umahi - 2012 - Journal of Global Ethics 8 (2-3):139-167.
Ethical considerations in the use of direct-to-consumer advertising and pharmaceutical promotions: The impact on pharmaceutical sales and physicians. [REVIEW]R. Stephen Parker & Charles E. Pettijohn - 2003 - Journal of Business Ethics 48 (3):279-290.
Wittgenstein on the language of rituals: the scapegoat remark reconsidered.Christopher Hoyt - 2012 - Religious Studies 48 (2):165-182.
Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won’t Cast Light on.Sergio Sismondo - 2013 - Journal of Law, Medicine and Ethics 41 (3):635-643.
AIDS is Not a Business.William Flanagan & Gail Whiteman - 2005 - International Corporate Responsibility Series 2:375-391.
Global health impact: A basis for labeling and licensing campaigns?Nicole Hassoun - 2012 - Developing World Bioethics 12 (3):121-134.
Establishing a “Duty of Care” for Pharmaceutical Companies.Remy Miller - 2010 - Hastings Center Report 40 (6):18-20.
Pharmaceutical Companies vs. the State: Who Is Responsible for Post-Trial Provision of Drugs in Brazil?Daniel Wei L. Wang & Octavio Luiz Motta Ferraz - 2012 - Journal of Law, Medicine and Ethics 40 (2):188-196.
Pharmaceutical medicine.D. M. Burley & Theodore Barker Binns (eds.) - 1985 - Baltimore, Md., U.S.A.: E. Arnold.
Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability under the Right to Health.Anand Grover, Brian Citro, Mihir Mankad & Fiona Lander - 2012 - Journal of Law, Medicine and Ethics 40 (2):234-250.
Social Responsibility and Global Pharmaceutical Companies.Norman Daniels - 2001 - Developing World Bioethics 1 (1):38-41.

Analytics

Added to PP
2013-10-26

Downloads
32 (#461,262)

6 months
1 (#1,346,405)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Pepe Chang
University of Texas at San Antonio

Citations of this work

Add more citations

References found in this work

Autonomy and Trust in Bioethics.Onora O'Neill - 2002 - New York: Cambridge University Press.
The epistemology of testimony.Jennifer Lackey & Ernest Sosa (eds.) - 2006 - New York: Oxford University Press.
Introduction.Jennifer Lackey - 2006 - In Jennifer Lackey & Ernest Sosa (eds.), The Epistemology of Testimony. Oxford University Press. pp. 1-24.

Add more references